Scientific Reports (Feb 2022)

Lamina-associated polypeptide 2α is required for intranuclear MRTF-A activity

  • Ekaterina Sidorenko,
  • Maria Sokolova,
  • Antti P. Pennanen,
  • Salla Kyheröinen,
  • Guido Posern,
  • Roland Foisner,
  • Maria K. Vartiainen

DOI
https://doi.org/10.1038/s41598-022-06135-5
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 19

Abstract

Read online

Abstract Myocardin-related transcription factor A (MRTF-A), a coactivator of serum response factor (SRF), regulates the expression of many cytoskeletal genes in response to cytoplasmic and nuclear actin dynamics. Here we describe a novel mechanism to regulate MRTF-A activity within the nucleus by showing that lamina-associated polypeptide 2α (Lap2α), the nucleoplasmic isoform of Lap2, is a direct binding partner of MRTF-A, and required for the efficient expression of MRTF-A/SRF target genes. Mechanistically, Lap2α is not required for MRTF-A nuclear localization, unlike most other MRTF-A regulators, but is required for efficient recruitment of MRTF-A to its target genes. This regulatory step takes place prior to MRTF-A chromatin binding, because Lap2α neither interacts with, nor specifically influences active histone marks on MRTF-A/SRF target genes. Phenotypically, Lap2α is required for serum-induced cell migration, and deregulated MRTF-A activity may also contribute to muscle and proliferation phenotypes associated with loss of Lap2α. Our studies therefore add another regulatory layer to the control of MRTF-A-SRF-mediated gene expression, and broaden the role of Lap2α in transcriptional regulation.